Data updated: Mar 10, 2026
DROPERIDOL
DROPERIDOL
Approved 1986-11-17
10
Indications
--
Phase 3 Trials
39
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1986-11-17
- Routes
- INJECTION, Injection
- Dosage Forms
- INJECTABLE, Injectable
Companies
Pfizer ABRAXIS PHARM SOLOPAK QUAD PHARMS IGI LABS INC WATSON LABS SMITH AND NEPHEW AstraZeneca LUITPOLD Hikma AM REGENT
Active Ingredient: DROPERIDOL
Website: ↗
DROPERIDOL Approval History
Loading approval history...
What DROPERIDOL Treats
10 FDA approvalsOriginally approved for its first indication in 1986 . Covers 10 distinct patient populations.
- Other (10)
Other
(10 approvals)- • Approved indication (Nov 1986)
- • Approved indication (Feb 1988)
- • Approved indication (Apr 1988)
- • Approved indication (Sep 1988)
- • Approved indication (Oct 1988)
- • Approved indication (Oct 1988)
- • Approved indication (Oct 1988)
- • Approved indication (Oct 1988)
- • Approved indication (Aug 1995)
- • Approved indication (Dec 2017)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DROPERIDOL FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.